Robert deGroof, PhD, has been named senior vice president, scientific affairs, for Alteon (Ramsey, New Jersey). deGroof will be responsible for leading the ongoing clinical development of Alteon's products. Prior to joining Alteon, deGroof was president of Keystone Scientific Management. He has been serving as a consultant to Alteon in regulatory and clinical affairs since May 1999.
* David Lee has been promoted from controller to vice president of finance and chief financial officer of CryoLife (Kennesaw, Georgia). He succeeds Edwin Cordell Jr., who resigned the positions to pursue other opportunities.
* Anthony Lombardo is the new president and CEO of E-Z-EM (Westbury, New York). Lombardo most recently was president of ALI Imaging Systems. E-Z-EM's wholly-owned subsidiary, AngioDynamics, manufactures medical devices for coronary, angiography, and therapeutic applications.
* Deborah Taylor has been appointed deputy chief financial officer and a deputy director in the office of financial management at the Health Care Financing Administration (Baltimore, Maryland). Taylor previously was assistant director in charge of audits and reviews at the General Accounting Office.
Matthew Rowan is the new president and CEO of the Health Industry Distributors Association (HIDA; Alexandria, Virginia). Rowan has served as acting president and CEO since December and joined HIDA as COO in 1998. Previously, he was deputy executive director at the Water Environment Federation.
Fariborz BoorBoor has been promoted to vice president and chief operating officer of the Jerneen subsidiary of Bio-Vascular (St. Paul, Minnesota). Previously, BoorBoor served as quality assurance manager at Plastech.
Scott Solano has been promoted to senior vice president, corporate technology, at Medtronic (Minneapolis, Minnesota). Solano is the former head of Medtronic's vascular business, and was CEO of Arterial Vascular Engineering (Santa Rosa, California) prior to its acquisition by Medtronic. The company also reported the promotion of Andy Rasdal, formerly vice president and general manager, coronary vascular, to replace Solano as senior vice president and president, vascular.
C. Leonard Gordon was named acting president and chief executive officer of NMT Medical (Boston, Massachusetts), replacing Thomas Tully, who resigned to pursue other business interests. Gordon is a co-founder, director, and former president and CEO of NMT, which makes medical devices, including those for cardiovascular applications.
Justine Corday has been named chairman and interim chief executive officer of Texas American BioMed (The Woodlands, Texas). Corday was elected to American BioMed's board in December 1999. Additionally, Marshall Kerr has been promoted from vice president, sales and marketing, to president and chief operating officer, replacing Steven Rash. Previously, David Arnold resigned as director for personal reasons, and the company's controller, Colene Blankenship, resigned to pursue other opportunities, but will remain as corporate secretary. American BioMed makes devices for minimally-invasive interventional cardiology and other surgical procedures.